Intravenous Lidocaine and Ketamine Infusions for Headache Disorders: A Retrospective Cohort Study.

Ray, Jason C; Cheng, Shuli; Tsan, Kirsten; Hussain, Hassan; Stark, Richard J; Matharu, Manjit S; Hutton, Elspeth

Ray, Jason C; Cheng, Shuli; Tsan, Kirsten; Hussain, Hassan; Stark, Richard J; Matharu, Manjit S; Hutton, Elspeth.

Afiliação

Ray JC; Department of Neurology, Austin Health, Melbourne, VIC, Australia.
Cheng S; Department of Neurology, Alfred Hospital, Melbourne, VIC, Australia.
Tsan K; Department of Neuroscience, Monash University, Melbourne, VIC, Australia.
Hussain H; Department of Neurology, Alfred Hospital, Melbourne, VIC, Australia.
Stark RJ; School of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC, Australia.
Matharu MS; School of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC, Australia.
Hutton E; Department of Neurology, Alfred Hospital, Melbourne, VIC, Australia.

Front Neurol ; 13: 842082, 2022.

Article em En | MEDLINE | ID: mdl-35356451

Palavras-chave

headache disorders; ketamine; lidocaine; medication overuse headache; migraine; status migrainosus

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Neurol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google